Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Body Packing
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.
Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL.
The graft-versus-lymphoma effect: fact, fiction, or opportunity?
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The graft-versus-lymphoma effect: fact, fiction, or opportunity?
The graft-versus-lymphoma effect: fact, fiction, or opportunity? J Clin Oncol. 2003 Oct 15; 21(20):3713-5.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Graft vs Tumor Effect
Hematopoietic Stem Cell Transplantation
Humans
Lymphoma, Non-Hodgkin
Neoplasm Recurrence, Local
Transplantation, Autologous
Transplantation, Homologous
authors with profiles
Michael Bishop